Rockefeller Capital Management’s Ascendis Pharma A/S ASND Stock Holding History

Rockefeller Capital Management’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$50.1K	Buy	188 +138	+276%	+$32.2K	﹤0.01%	3370
2026 Q1	$11.4K	Buy	50 +15	+43%	+$3.36K	﹤0.01%	3940
2025 Q4	$7.46K	Sell	35 -77	-69%	-$15.9K	﹤0.01%	3934
2025 Q3	$22.3K	Buy	+112	New	+$20.9K	﹤0.01%	3306
2023 Q1	–	Sell	-24	Closed	-$1K	–	2098
2022 Q4	$1K	Buy	24 +8	+50%	+$929	﹤0.01%	3638
2022 Q3	$1K	Sell	16 -112	-88%	-$10.6K	﹤0.01%	3668
2022 Q2	$11K	Buy	128 +118	+1,180%	+$11.1K	﹤0.01%	3051
2022 Q1	$1K	Sell	10 -19	-66%	-$2.2K	﹤0.01%	3697
2021 Q4	$3K	Buy	+29	New	+$4.31K	﹤0.01%	3407
2021 Q3	–	Sell	-50	Closed	-$6K	–	3685
2021 Q2	$6K	Hold	50	–	–	﹤0.01%	2955
2021 Q1	$6K	Buy	+50	New	+$7.6K	﹤0.01%	2814
2020 Q2	–	Sell	-100	Closed	-$11K	–	2572
2020 Q1	$11K	Hold	100	–	–	﹤0.01%	1706
2019 Q4	$14K	Hold	100	–	–	﹤0.01%	1497
2019 Q3	$10K	Hold	100	–	–	﹤0.01%	1406
2019 Q2	$12K	Hold	100	–	–	﹤0.01%	1165
2019 Q1	$12K	Buy	+100	New	+$8.76K	﹤0.01%	1421

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Rockefeller Capital Management's ASND Position: Q2 2026 in Review

Rockefeller Capital Management increased its Ascendis Pharma A/S (ASND) stake by 276% in Q2 2026, buying an estimated $32.2K and bringing the position to 188 shares worth $50.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3370.

Rockefeller Capital Management first reported a position in ASND in Q1 2019 and has held it in 16 quarters since. 311 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Rockefeller Capital Management held 188 shares of Ascendis Pharma A/S worth $50.1K as of Q2 2026.
Rockefeller Capital Management bought 138 Ascendis Pharma A/S shares in Q2 2026, an estimated $32.2K.
Ascendis Pharma A/S made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #3370 holding.
Rockefeller Capital Management first reported a position in Ascendis Pharma A/S in Q1 2019 and has held it in 16 quarters since.
311 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.